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The femoral artery has been the primary percutaneous-based arterial access site for coronary artery catheterizations for
more than three decades. Noncardiac percutaneous-based procedures have also been performed primarily with femoral
access and have increased in number exponentially by vascular specialists in past decades. Groin complications are
infrequent in incidence after femoral arterial access for cardiac and peripheral diagnostic and interventional cases, with
groin hematomas and pseudoaneurysms being the most common. Until ultrasound-based treatment modalities became
the mainstay of treatment, vascular surgeons were the primary specialty managing pseudoaneurysms, but now other
specialties also manage these cases. This review outlines the clinical implications and current issues relevant to under-
standing the ideal treatment strategy for this common complication. (J Vasc Surg 2014;60:1359-66.)Historically, the common femoral artery has been, by far,
the most commonly used percutaneous arterial access site.
The traditional method of entry into the femoral arterial sys-
tem has been the modiﬁed Seldinger technique. There is
debate over which technical method to use as a landmark
for entry (“best pulse,” guidance with ﬂuoroscopy, and
most recently, ultrasound-guided puncture) to achieve suc-
cessful arterial cannulation with sheath introduction.
Many patients rate their interventional experience on the
degree of access site discomfort encountered during and af-
ter the procedure. This is comparable to a patient undergo-
ing an open reconstruction and judging the skill of the
surgeon on the external appearance of the incision. With
percutaneous-based procedures, patients are not aware of
whether the operator achieved optimal luminal gain with
stent placement or whether asymptomatic distal emboliza-
tion occurred, but they are aware of access complications.
Many access-related complications can occur, and
although some are life- and limb-threatening, such as retro-
peritoneal hemorrhage or arterial occlusion, emergency
surgery is rare, occurring in well below 1% of patients.
Rapid and persistent hemostasis is essential for a return to
the prepuncture state. Any loss of hemostasis at the entrythe Department of Surgery, West Virginia University.
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below the inguinal ligament.
At the most urgent end of the spectrum is an expand-
ing hematoma, secondary to ongoing hemorrhage within
the soft tissue space that may require urgent endovascular
or surgical intervention if pressure application to the site
cannot resolve the problem. At the other end of the spec-
trum is a temporary hemorrhage that subsides, resulting in
hematoma or somewhere in between. The ﬁbrin shell pre-
vents an expanding hematoma but lacks arterial wall seal-
ing, which allows for ongoing blood extravasation from
the artery into a contained area, a “false aneurysm sac,”
which is described as a femoral artery pseudoaneurysm.
This review focuses on this speciﬁc problemdiatrogenic
femoral artery pseudoaneurysmsdincluding incidence,
risk factors, diagnostic approach, management, new tech-
niques, and unresolved issues.
INCIDENCE
The reported incidence of femoral artery pseudoaneur-
ysms varies widely in the literature, with some society guide-
lines expecting an acceptable rate of <0.2%.1 In drastic
comparison, a prospective study of >1000 patients demon-
strated pseudoaneurysms in 3.8% of patients when routine
duplex imaging was performed.2 Although this study is
>20 years old, a more recent study demonstrated similar re-
sults when routine ultrasound imaging was performed, with
an incidence of 2.9% in >500 consecutive patients.3
RISK FACTORS
Multiple patient-related and procedure-related factors
have been identiﬁed in the increasing incidence of femoral
artery pseudoaneurysms. Patient-speciﬁc factors include
body mass index, gender, degree of arterial calciﬁcations,1359
Table. Risk factors for femoral pseudoaneurysms
Patient-related factors
d Advanced age
d Gender: Female > male
d Body habitus: increased body mass index
d Platelet count: increased risk with decreasing platelet count
Procedural-related factors
d Puncture site: below the bifurcation
d Sheath size: increasing size
d Interventional procedures higher risk than diagnostic
procedures
d Urgent vs elective procedures
d Femoral artery and vein cannulation
d Anticoagulation and antiplatelet administration and continued
administration postprocedure
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factors include the urgency of the procedure, diagnostic
vs interventional procedures, the site of arterial cannula-
tion, the size of the sheath, combined arterial and venous
access, procedural antiplatelet medication use, and anticoa-
gulation.4 Postprocedural factors that have been associated
with an increased risk of development of a femoral pseu-
doaneurysm include the need for continued anticoagula-
tion and urgent percutaneous coronary intervention. In a
study of >2000 patients undergoing emergency percuta-
neous coronary intervention who had duplex imaging of
the groin, the incidence of pseudoaneurysms was 2.3%
higher than what has been reported in most nonemergency
series. Other statistically signiﬁcant risk factors for pseudoa-
neurysms in this study included gender and age, with
women and those aged >75 years at increased risk for
pseudoaneurysms during their hospitalization.5 The Table
lists the risk factors for the development of
pseudoaneurysms.
DIAGNOSIS
The initial step in the diagnosis of femoral artery pseu-
doaneurysms should always be the physical examination.
Unfortunately, secondary to the painful nature of the adja-
cent hematoma and recent catheterization, the groin is
extremely sensitive to palpation and examination. The
limb may also become swollen secondary to underlying he-
matoma or pseudoaneurysm compression of the femoral
vein that rarely results in sufﬁcient compression to cause
deep venous thrombosis.
A prospective study by Mlekusch et al4 evaluated clin-
ical parameters in identifying femoral artery pseudoaneur-
ysms. The presence of a pulsatile mass had a 100%
positive and negative predictive value. Additional clinical
parameters, including bruit, nonpulsatile mass, or superﬁ-
cial painful pulse palpation, were less accurate in a study
of 23 patients with pseudoaneurysms.4 In a larger prospec-
tive study, Kent et al6 reported that the physical examina-
tion was extremely accurate, with a sensitivity of 83% and
a speciﬁcity of 100% in 53 patients who were examined
by vascular surgeons before their duplex examinations.Although these series demonstrate impressive accuracy of
physical examination, this depends to a large extent on
observer acuity, particularly for small pseudoaneurysms.
Therefore, the duplex examination has become the gold
standard for the deﬁnitive diagnosis and development of
a management strategy.
Laboratory parameters may also aide in the diagnosis
of pseudoaneurysms. A study by Mlekusch et al4 demon-
strated that the clinical examination was very accurate
and correlated with a positive ultrasound imaging for pseu-
doaneurysm. All patients with duplex conﬁrmation
of false aneurysms had a preoperative platelet count
of <200,000/L, whereas the 250 patients without a false
aneurysm had platelet counts >200,000/L.4 The use of a
D-dimer test after percutaneous-based access has also
been evaluated. A study by Hoke et al7 compared 72
controls with 48 patients with pseudoaneurysms. They
demonstrated higher D-dimer values in patients with pseu-
doaneurysms compared with controls (1.9 vs 0.8 mg/mL;
P < .001) and an increasing pseudoaneurysm size with
increasing quartile of D-dimer values. They concluded
that, with a negative predictive value of 90%, a D-dimer
value of <0.67 mg/mL could be used as a screening labo-
ratory assessment before duplex imaging. A noteworthy
ﬁnding was that all patients with a pseudoaneurysm had
preprocedural platelet counts <200,000/L and no patients
with platelet counts >200,000/L had a pseudoaneurysm.7
The potential beneﬁt of these two laboratory values in
selecting which patients need duplex examinations of groin
hematomas for suspected or potential pseudoaneurysms is
obvious. The scenario is similar to the emergency depart-
ment D-dimer testing in patients with a swollen leg. With
a high negative predictive value, patients with platelet
counts >200,000/L and D-dimer levels within normal
reference ranges could forego a duplex evaluation and
reduce negative workups and, ultimately, health care dol-
lars. The population of this study was small, and larger
studies are needed to verify these results, and as stated
earlier, the diagnosis is best made by duplex imaging for
now.
IMAGING
Duplex ultrasound remains the cornerstone of imaging
for patients with groin complications after catheterization.
Duplex is not only the initial imaging modality of choice
but also the primary method of monitoring with observa-
tion and the modality for direct nonsurgical therapy (ie,
compression/thrombin injection).
Duplex imaging must differentiate a pseudoaneurysm
from other pathology and accurately identify patients
who need future imaging or an immediate intervention.
Duplex imaging includes ultrasound for adequate assess-
ment of groin pathology and B-mode imaging for
measuring hypoechoic collections (ie, hematoma); how-
ever, B-mode alone cannot determine the presence of a
persistent arterial defect. A 5- to 7-mHz linear transducer
is used initially for evaluation, and a sector transducer is
reserved for obese patients or those with a large groin
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the hypoechoic mass to differentiate a simple hematoma
from a pseudoaneurysm. Conﬁrmation that no connection
is demonstrated with the adjacent venous system is imper-
ative. Doppler waveform analysis with a low resistance
pattern that implies an arteriovenous ﬁstula would exclude
management with thrombin injection.
Color ﬂow can aid in the anatomic characterization of
the aneurysm, including neck diameter, length of the tract
from the neck to the aneurysm sac(s), number of sacs, and
size in millimeters. The ﬂow volume and maximum aneu-
rysm diameter should be recorded. Color ﬂow will demon-
strate the classic “yin-yang” shape as arterial blood leaves
the arterial defect and reﬂects back within the artery.
Doppler waveform analysis should also be performed to
rule out the presence of concomitant arteriovenous ﬁstulae,
which have a characteristic low resistance pattern with a
considerable diastolic ﬂow component.
MANAGEMENT
Observation and natural history. As in true aneu-
rysms of the peripheral arteries, observation plays an impor-
tant role until a size threshold is met. More than half dozen
studies in the 1990s reported pseudoaneurysm observa-
tions. One of the ﬁrst series, by Kresowik et al,8 studied
seven pseudoaneurysms, ranging in size from 1.3 to
3.5 cm, that were monitored weekly with serial duplex
examinations. All pseudoaneurysms successfully spontane-
ously thrombosed #4 weeks of the initial diagnosis.8
A larger series was published in 1992 by Paulson
et al,9 which included 24 pseudoaneurysms that were
studied serially with color Doppler ultrasound imaging.
Detailed duplex characteristics were evaluated to deter-
mine which patients had successful thrombosis with obser-
vation compared with those who eventually underwent
intervention. This included the volume of ﬂow, ratio of
forward to reverse ﬂow, duration of diastolic ﬂow, and
neck length. Only the volume of ﬂow in the lumen was
statistically different, with smaller ﬂow volumes associated
with spontaneous closure (1.8 mL vs 4.4 mL; P ¼ .02).
Unlike the previous series by Kresowik et al,8 only 58%
had spontaneous thrombosis without intervention. Unfor-
tunately, this series did not report the indications for
intervention.9
Also, contrary to the success with observation by
Kresowik et al,8 Kent et al10 reported that one-third of
observed femoral pseudoaneurysms required repair. Only
nine of 16 pseudoaneurysms spontaneously thrombosed,
and the size did not necessarily correlate with who would
require repair. Of note, three of the seven patients who
required repair needed ongoing anticoagulation from the
time of diagnosis until surgical intervention. The results
from this study led the authors to recommend repair in pa-
tients who require anticoagulation and raised caution in us-
ing duplex parameters to predict which patients can be
treated conservatively.10
In a small study by Samuels et al11 in 1997, 11 patients
were evaluated with duplex parameters to detectsuccessful thrombosis. The length of the neck predicted
earlier successful thrombosis, with those with a neck
length >0.9 cm undergoing spontaneous thrombosis at
a mean of 9 days vs 52 days for those with shorter
neck lengths.11
The largest series in the literature on observation of
pseudoaneurysms, and likely the most widely quoted, is
the work by Toursarkissian et al12 during the same year.
Their study included 147 patients with pseudoaneurysms
with a maximum diameter <3 cm, which was more patients
than the sum of all the previous series combined. The main
exclusions for enrollment were the need for immediate sur-
gical intervention or the use of anticoagulants. Intervention
was avoided in 89% of patients, with a mean time to throm-
bosis of 23 days. The average number of duplex examina-
tions was higher, as expected, in those with serial
examinations compared with those with immediate surgery
(2.6 per patient with observation).12
Ultrasound-guided compression. In the early 1990s,
surgical repair was the mainstay for postcatheterization
false aneurysm. Fellmeth et al13 reported a >90% success
with ultrasound-assisted compression, encouraging a
nonsurgical approach as the ﬁrst line of management.
Throughout the 1990s, procedures were done in radiology
suites under direct physician supervision with ultrasound-
directed compression, which dramatically reduced the
number of surgical interventions. The technique involves
placement of the ultrasound probe on the groin with direct
visualization of the neck of the aneurysm. Pressure is
applied to the probe to eliminate ﬂow through the aneu-
rysm neck to the aneurysm, with maintenance of arterial
ﬂow within the native femoral artery. Continued evaluation
at 5- to 10-minute intervals to assess arrest of ﬂow into the
aneurysm sac is typical. This technique is continued until
patient discomfort does not permit further compression,
operator fatigue is too great, or successful aneurysm
thrombosis is achieved. Most of large series report an
average compression time of nearly 30 minutes.
Limitations of this technique include patient discom-
fort, frequent need for sedative administration for patient
comfort, and failure rates higher than those achieved with
duplex-guided thrombin injection (DGTI). The factors
most commonly associated with failure of compression
included the ongoing need for anticoagulation and
increasing size of the aneurysm sac.14 In a series by Schaub
et al14 of 219 pseudoaneurysms, the highly statistically sig-
niﬁcant predictors of failure of ultrasound-guided compres-
sion were ongoing anticoagulation and length of aneurysm
neck (<10 mm), with a success rate of 71% vs >93%,
respectively, for both subgroups. The aneurysm volume
was statistically signiﬁcant in the compression bandage
cohort only in this large series but not with ultrasound-
guided compression.14
DGTI. The initial technique was described 25 years ago
by Cope andZeit,15 before the widespread use of ultrasound-
guided compression instead of operative therapy. DGTI has
supplanted ultrasound-guided compression as the initial
therapy of choice, secondary to the speed of thrombosis,
Fig 1. Color duplex imaging of a femoral pseudoaneurysm, with
to-and-fro ﬂow noted, with neck diameter with calibrated mea-
surement of the aneurysm neck.
Fig 2. Echogenic needle tip is visualized in B-mode at the pe-
riphery of the pseudoaneurysm sac (away from the neck of the
aneurysm).
Fig 3. Successful thrombosis with lack of ﬂow in the pseudoa-
neurysm and persistent ﬂow in femoral arteries below the pseu-
doaneurysm sac is noted.
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improved success in most series.
In most centers, the radiology department offers this
therapy; however, at our institution, the vascular surgery sec-
tion has been the primary service responsible for evaluation
and management of our own groin-related complications or
those from our cardiology colleagues for more than a
decade. The procedure consists of the following steps:
d Complete examination of arterial anatomy of affected
femoral artery
B Site of origin of the aneurysm: common femoral or
femoral/deep femoral
B Waveform pattern of outﬂow arterial tree
B Size of the aneurysm, including the number of lobes
and the dimensions of ﬂow lumen
B Length and diameter of the aneurysm neck (Fig 1)
d Prepare the groin site with antiseptic and use a sterile
probe cover
d Local anesthetic should be considered at skin entry site
d Needle size: 19- to 25-gauge spinal needle with tuber-
culin 1-mL syringe
d Under B-mode imaging, identify the sac most adjacent
to the artery and direct the needle tip to the periphery
of the aneurysm sac “away from the neck”
d Inject 0.1-mL aliquots of 1000 IU/mL topical
thrombin after reconstitution
d Alternate between color Doppler and B-mode imaging
during the injection to assess for thrombosis (Figs 2
and 3)
d After thrombosis is achieved, assess the femoral arteries
for Doppler and color ﬂow, conﬁrming similar pattern
as preprocedure
d Bed rest for 2 hours, then allow ambulation
Critical technical points:
d Maintain the needle tip in the periphery of the aneu-
rysm sac.d Accessing the aneurysm sac in obese patients requiring
curvilinear probes is more difﬁcult secondary to signif-
icantly obscured visualization.
d Do not inject an aneurysm with a sac size <1 cm.
Highest arterial thrombosis risk.
d Thrombosis or embolization is rare: Use the minimal
amount of thrombin to occlude the aneurysm and al-
ways perform postinjection imaging, including
Doppler and color ﬂow imaging of femoral artery
and waveform analysis or peripheral vascular resistance.
In a prospective nonrandomized study of 274 patients
with femoral artery pseudoaneurysms treated with DGTI,
52 (19%) were being treated with anticoagulation at the
time of therapy. The overall success rate was 97% and
was not adversely affected by anticoagulation use. Of the
seven failures with the ﬁrst injection, three underwent a
successful second injection, three had successful adjunct
ultrasound-guided compression therapy, and one patient
required surgical correction.16
The largest nonrandomized study directly comparing
ultrasound-guided compression and DGTI was reported
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sion and 131 with DGTI, the success rate favored DGTI
(96%) over ultrasound-guided compression (75%). The pri-
mary reason for compression failure was pain with
compression or an aneurysm depth that did not allow for
adequate compression, whereas the failures occurring dur-
ing DGTI were primarily related to intra-arterial injection
of aneurysms <2.5 cm and short necks.17
In our experience of >200 DGTI, we have had one pa-
tient with acute limb ischemia. This patient presented
immediately after the injection procedure with common
femoral artery occlusion and underwent successful open
surgical thrombectomy. Most other series report symptoms
immediately or within several hours, with varying degrees
of management. Percutaneous-based thrombectomy and
even catheter-directed lysis are options in patients with
extensive arterial occlusion.
Gorge et al18 prospectively evaluated the effectiveness of
ultrasound-guided compression in 36 patients with current
administration of acetylsalicylic acid and clopidogrel. If
compression failed to achieve complete aneurysm thrombosis
after 40 minutes, then DGTI was performed. In addition,
two-thirds of patients had received heparin or enoxaparin
#12 hours of treatment. Only 17% of patients had successful
thrombosis with compression alone, with 30 patients subse-
quently receiving DGTI, with a success rate of 93%.18
Previously, our group conducted a literature review on
the recurrence of pseudoaneurysm after successful DGTI
and found an incidence of only 3.4% in 1375 reported
successful injections. The use of routine repeat duplex
examinations, therefore, could be questioned, especially
in a cost-containment environment, after a successful
thrombin injection procedure.19 In a previously reported
series by our group, >100 procedures were performed,
with no intra-arterial injections, embolic complications, or
allergic reactions reported.
Other described techniques. A host of other tech-
niques have been used to successfully treat postcatheteriza-
tion false aneurysms. Many agents have been injected into
the aneurysm sac to promote thrombosis, of which, topical
reconstituted thrombin is the most commonly used agent,
and some series have reported the use of saline, glue, and
coils. Saline by far is the least expensive agent, rivaled
only by the cost of topical thrombin at <US $50, whereas
coils and glues are >$250 at our institution and may serve
as a nidus for infection.
Endovascular techniques, typically from a contralateral
femoral access, can be used but may result in a contralateral
femoral complication. The use of covered stents and bare
stents with coil placement through the stent struts (ie, as
used in intracranial therapy) should be avoided, secondary
to the ﬂexion point of the common femoral artery, unnec-
essary costs of products, etc.
Surgery. Surgical exploration for groin-related com-
plications continues to have a role in select cases. Large
hematomas with impending skin necrosis or that continue
to expand should undergo prompt exploration. In addi-
tion, suspected infected pseudoaneurysms, which rarelyoccur, should also undergo surgical repair of the arterial
defect. Severe pain and nerve compression with neurapraxia
are also indications for surgical decompression of the
overlying hematoma and pseudoaneurysm repair.
Technical considerations include the method of obtain-
ing proximal arterial control (ie, standard groin incision vs
suprainguinal incision) for control of the distal external iliac
artery and orientation of the incision and are at the discre-
tion of the surgeon. A groin incision is generally safe and
effective for pseudoaneurysms in contrast to exploration
for a “high stick” resulting in a retroperitoneal hematoma.
Unless the patient has had a previous vertical incision, our
group favors a transverse incision because our anecdotal
experience suggests a lower frequency of incisional compli-
cations. Technical aspects include meticulous dissection of
the femoral artery to identify the arterial defect, ensuring
that the suture repair incorporates the full thickness of
the arterial wall and not solely “bites” of the adventitia
and ﬁbrin layer covering the artery. During surgical explo-
ration, a thorough circumferential exposure of the common
femoral artery, superﬁcial femoral artery, and profunda is
required to look for possibility of multiple injury sites and
“through-and-through” punctures that leave posterior wall
injuries. Simple interrupted repair with the superior and infe-
rior edges of the defect approximated by intima to adventitia
directional passage of the needle is sufﬁcient. Large hema-
tomas adjacent to false aneurysms will often leave a cavity
once evacuation of the hematoma has been achieved, and
consideration for closed suction drainage should be enter-
tained. Rarely, large arterial defects require patch angio-
plasty, and autologous tissue should be applied secondary
to the unusual high rate of wound-related complications
associated with this operation.
Complications associated with operative intervention
are mostly surgical-site related. Garcia et al20 recently re-
ported outcomes of 79 patients managed with operative
repair, and the most common complication was blood
loss requiring transfusion. This series also reported inci-
sional dehiscence in 12% and infection in 19% of proce-
dures.20 This includes a 17-year experience with nearly
one-quarter developing postoperative complications.
Bleeding was reported most frequently, with wound-
related complications reported in 6.5% of the 92 patients.
Of note, patients with complications experienced a longer
intensive care time and hospital length of stay. Risk factors
for complications included older age and the presence of
chronic obstructive pulmonary disease.21 Also, femoral
nerve injury may occur because the native anatomy may
be obscured by the overlying hematoma. A recommended
management algorithm is presented in Fig 4.
RANDOMIZED TRIALS
Several small randomized trials have compared thera-
pies or technical aspects of treatment of femoral pseudoa-
neurysms. Paschalidis et al22 randomized 168 patients to
manual compression with and without ultrasound guid-
ance. Therapy was performed for up to 60 minutes, and
repeat sessions were performed in unsuccessful cases.
Fig 4. Femoral pseudoaneurysm management algorithm. CABG, Coronary artery bypass grafting.
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sion compared with standard compression (4.7% vs 9.4%).
However, ultimate success was similar between the two
methods, with 2.3% of the standard compressions requiring
surgery vs 1.1% of the ultrasound-guided therapy proce-
dures. The length of treatment was not reported for either
cohort.22
Another study randomized 38 patients to compression
with a FemoStop (Radi Medical Systems, Uppsala, Sweden)
or to ultrasound-guided compression. Both modalities
required w30 minutes for successful obliteration of
the aneurysm. Success rates were similar between both co-
horts, with a success rate of 79% with the FemoStop device
and 74% in patients undergoing ultrasound-directed
compression.23
Ultrasound-guided compression and DGTI were
compared in a small randomized series by Lonn et al.24
However, only 30 patients were randomized to the two
treatment modalities. A dramatic difference was found in
favor of thrombin injection, with all 15 patients receiving
successful thrombosis in contrast to a 13% initial success
rate and only a 40% success rate after two treatments in pa-
tients with compression only. Ultrasound-guided compres-
sion was used with a FemoStop. The balloon was raised
above systolic pressure and left in place for 30 minutes,
then repeated for 30 minutes if the aneurysm sac was not
successfully closed, followed by bed rest until the following
morning. All failures in the compression cohort were ulti-
mately successfully treated by thrombin injection.24
The technique of bolus vs slow injection of topical
thrombin into the false aneurysm has been compared in
73 patients. The two groups were similar in demographics
and characteristics of the aneurysm (neck length/width
and blood ﬂow at the neck). The overall success was similar
between the two groups. A pulse oximeter was placed onthe great toe of the treated limb, and clinical and objective
decreases in the oxygen saturation were considered to have
embolization. The frequency of clinical or objective devel-
opment of embolization was w30% in both groups. Of
note, >70% of the aneurysms occurred from the superﬁcial
femoral or deep femoral arteries, with <30% from the com-
mon femoral artery.25
COCHRANE REVIEWS
Two reviews have been conducted by Tisi et al26,27 on
the subject of femoral pseudoaneurysms. The ﬁrst review
was in 2006 and compared surgical vs nonsurgical interven-
tion for femoral pseudoaneurysms; however, surgical repair
was not an arm for either of the studies reviewed, only
nonsurgical techniques. The limitation of this initial review
was based on the evaluation of only two small randomized
trials, which were mentioned above. The ﬁrst compared the
use of the FemoStop device vs ultrasound-guided compres-
sion, and the second compared ultrasound-guided
compression vs DGTI. Only limited conclusions can be
achieved from reviewing these two small studies.
The second review was conducted only 3 years later, with
two additional small studies added. This additional review
compared two compression methods with ultrasound-
guided compression, and two studies compared ultrasound-
guided compression vs DGTI. The results of such small
cohorts fail to support a compression-ﬁrst approach, as
Tisi et al26 have recommended. It appears clear from the
aggregate of retrospective studies that pseudoaneurysms of
the currently acceptable size threshold (>3 cm) to warrant
treatment are more effectively treated with a DGTI.
UNSOLVED ISSUES WITH TREATMENT
What is the current natural history of pseudoaneur-
ysms? All of the natural history studies were reported
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recently been manufactured as a generic medication with
a decreased price, which has potentially resulted in
increased use. Clopidogrel (Sanoﬁ-Aventis, Bridgewater,
NJ), was released in 1997, and may affect the development
of spontaneous thrombosis of pseudoaneurysms. In addi-
tion, newer more potent oral antiplatelet agents have
recently reached the market.
Additionally, there are currently no guidelines for an
ideal management strategy such as size threshold and
which size variables should be measured to determine
treatment (ie, ﬂow, lumen, or total aneurysm size including
thrombus). Should the threshold be lowered for patients
with new-generation antiplatelet or anticoagulants agents?
There is enough evidence to suggest that ongoing antico-
agulation reduces the likelihood of spontaneous throm-
bosis or thrombosis with standard compression.
What perioperative restrictions should be included for
patients after DGTI? Currently, at our institution, we are
performing outpatient thrombin injections in patients
who are diagnosed with pseudoaneurysms after discharge.
After a successful thrombin injection, we order 2 hours
of bed rest and then discharge the patient. Patients diag-
nosed with pseudoaneurysms are discharged 2 hours after
the procedure to limit unnecessary hospital days.
Additionally, with the low rate of recurrence, should
any imaging be recommended after documented throm-
bosis? Furthermore, in an ever-increasing push for cost
containment, should patients have a duplex examination
3 weeks after the initial diagnosis of a pseudoaneurysm to
assess for successful thrombosis with observation, because
this is the mean time in previous studies for successful
spontaneous thrombosis, or should selective thrombin in-
jections of smaller pseudoaneurysms be performed with
clinical follow up to reduce health care costs?
CONCLUSIONS
Although the incidence of femoral pseudoaneurysms is
low, the increasing percutaneous volume by vascular
surgeons and other specialists requires a thorough under-
standing of this complication. Most small pseudoaneurysms
will spontaneously resolve without intervention, and obser-
vation is prudent. Technical aspects of noninvasive man-
agement should be in the armamentarium of vascular
surgeons who provide comprehensive management of the
vascular patient in the interpretation of images for diag-
nosis, noninvasive ultrasound-guided therapies, and tradi-
tional surgical intervention when indicated.
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